Can Molina <a href="https://<a href="https://healthylife7.com/8-ways-wildfire-smoke-can-harm-your-health/” title=”8 Ways Wildfire Smoke Can Harm Your Health”>healthylife7.com/denny-sanford-leaves-legacy-in-healthcare-and-beyond/” title=”Denny Sanford leaves legacy in healthcare and beyond”>Healthcare (MOH) Trade At A Premium After Its Contract Win?
Bailey Pemberton
Sat, July 18, 2026 at 8:41 PM GMT+5:30
3 min read
- MOH
+0.24%
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE
Molina Healthcare stock has climbed over the past year and recently touched a 52 week high after winning a large Illinois Medicaid contract, yet its valuation checks still lean expensive and the long term share price record over three years is weak. For investors, that mix of recent enthusiasm and a low value score raises the question of whether the current price already builds in much of the good news
Over the past three years, Molina Healthcare shares have declined 29.2%, which contrasts with the stronger returns seen over shorter periods and highlights a tougher longer term journey for shareholders
The new HealthChoice Illinois Medicaid contract can support expectations for future revenue, but execution risks around large public contracts and policy decisions may weigh on how much value investors ultimately see in the stock
Molina Healthcare passes only 2 of 6 valuation checks, and that low value score suggests the stock is not a clear bargain on broader metrics
The issue now is whether Molina Healthcare’s recent contract win and share price strength are enough to justify paying what looks like a premium on the current valuation checks
Find out why Molina Healthcare’s 23.2% return over the last year is lagging behind its peers
Is Molina Healthcare Getting Expensive on Earnings?
The P/E ratio is a useful way to see how much investors are paying for each dollar of Molina Healthcare earnings. Molina Healthcare currently trades on about 62.4x earnings, which is well above the Healthcare industry average of 26.0x and also ahead of the peer average of 32.8x
The fair P/E multiple implied by broader factors such as size, margins and risk sits lower at around 45.3x, so the current 62.4x level implies a clear premium to what this model suggests investors might typically pay for Molina Healthcare. Despite the recent Illinois Medicaid contract win lifting sentiment around the stock, the valuation signal here is that investors are already paying up for that optimism
On this P/E yardstick, Molina Healthcare stock currently screens as overvalued
See what the numbers say about this price — find out in our valuation breakdown
The Molina Healthcare Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives pick up where the Molina Healthcare valuation puzzle leaves off. They spell out what kind of future growth, margins and earnings would need to occur for the stock to be worth materially more or less than it is today, and they sit on the company’s Community page. Rather than focusing on a single multiple or model output, each narrative lays out its underlying assumptions so you can compare them with Molina Healthcare’s actual results as they are reported
